Kamada counsel awarded 29,485 and 60,000 options
The options vest in four equal installments, with 25% vesting on each anniversary of the grant date.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Nir Livneh, Kamada's VP, General Counsel, reported two indirect employee stock option awards held by a trustee under the company's 2011 Share Award Plan on August 27, 2026: 29,485 options at a $5.43 exercise price and 60,000 options at $7.44. The reported USD exercise prices were adjusted in connection with a special cash dividend. The options vest in four equal installments, with 25% vesting on each anniversary of the grant date. No Rule 10b5-1 plan is reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (right to buy) F1, F4, F2, F3 | 29,485 | $0.00 | $0.00 |
| Grant/Award | Employee Stock Option (right to buy) F1, F5, F2, F3 | 60,000 | $0.00 | $0.00 |
Footnotes (5)
- F1. The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.
- F2. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.
- F3. Held by trustee under the Company's 2011 Share Award Plan.
- F4. This option was previously reported as covering 29,485 ordinary shares at an exercise price of $5.59. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.
- F5. This option was previously reported as covering 60,000 ordinary shares at an exercise price of $7.61. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.
Key Figures
Key Terms
Employee Stock Option (right to buy) financial
exercise price financial
vest financial
record date financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Why did KMDA's option exercise prices change?
AI-generated analysis. How Rhea-AI works. Not financial advice.